---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-022445"
form_type: "8-K"
ticker: "NAII"
cik: "0000787253"
company_name: "NATURAL ALTERNATIVES INTERNATIONAL INC"
filed_at: "2021-09-21T23:59:59+00:00"
generated_at: "2026-06-29T02:28:35.594264+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# NAI reports record FY2021 sales $178.5M, net income $10.8M; guides FY2022 sales up 5-10%

## Summary
- Q4 net sales $44.4M (+26.5% YoY); diluted EPS $0.47 vs $0.27 prior year.
- FY2021 net sales $178.5M (+50.2%); net income $10.8M vs net loss $1.6M in FY2020.
- CarnoSyn royalty revenue up 102.6% in Q4; private-label manufacturing sales +54.6% for year.
- FY2022 guidance: net sales +5-10% YoY; operating income 7-9% of sales; first half slower due to supply chain.
- Appoints Dr. Guru Ramanathan (former GNC Chief Innovation Officer) as independent director.

## SEC filing metadata
- accession: 0001437749-21-022445
- form_type: 8-K
- ticker: NAII
- cik: 0000787253
- company_name: NATURAL ALTERNATIVES INTERNATIONAL INC
- filed_at: 2021-09-21T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/787253/000143774921022445/0001437749-21-022445-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/787253/000143774921022445/naii20210920_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-022445
- JSON: https://secwatch.observer/filing/0001437749-21-022445.json
- Plain text: https://secwatch.observer/filing/0001437749-21-022445.txt

## Key facts
- Executive change
  Dr. Guru Ramanathan was appointed as Director at NATURAL ALTERNATIVES INTERNATIONAL INC.
  - Action: appointed
  - Role: Director
  source text: The Board appointed Dr. Guru Ramanathan to complete the remaining term of the deceased director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/787253/000143774921022445/0001437749-21-022445-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.